REHOVOT, Israel,
April 2, 2021 /PRNewswire/ --
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading
computational biology company focused on revolutionizing product
discovery and development in multiple life-science based
industries, announced today that it has filed its annual report on
Form 20-F for the fiscal year ended December
31, 2020 with the U.S. Securities and Exchange Commission
(the "SEC").
The annual report, which contains the Company's audited
consolidated financial statements, can be accessed on the SEC
website
at http://www.sec.gov/
as well as via the Company's website at
http://www.evogene.com/investor-relations.
The Company will deliver a hard copy of its annual report,
including its complete audited consolidated financial statements,
free of charge, to its shareholders upon request to the Company
Media
Contact: ir@evogene.com.
About Evogene
Ltd.:
Evogene (NASDAQ: EVGN), (TASE: EVGN) is a leading
computational biology company focused on revolutionizing product
discovery and development in multiple life-science based
industries, including human health and agriculture, through the use
of its broadly applicable Computational Predictive Biology (CPB)
platform. The CPB platform, incorporating a deep
understanding of biology leveraged through the power of Big Data
and Artificial Intelligence, has been designed to computationally
discover and guide the development of life-science products based
on microbes, small molecules and genetic elements. Utilizing
the CPB platform, Evogene and its subsidiaries are now advancing
product pipelines for human microbiome-based therapeutics through
Biomica Ltd., medical cannabis through Canonic Ltd., ag-biologicals
through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., and
ag-solutions for castor oil production through Casterra
Ltd. For more information, please
visit www.evogene.com.
Evogene Investor Contact:
Aviva Banczewski / Rivka
Neufeld
Investor Relations and Public Relations Manager
E: IR@evogene.com
T: +972-8-931-1900
US Investor Relations:
Joseph Green
Edison Group
E: jgreen@edisongroup.com
T: +1 646-653-7030
Laine Yonker
Edison Group
E: lyonker@edisongroup.com
T: +1 646-653-7035
Logo -
https://mma.prnewswire.com/media/890385/Evogene_Logo.jpg
View original
content:http://www.prnewswire.com/news-releases/evogene-files-annual-report-for-the-year-ended-december-31-2020-301261549.html
SOURCE Evogene Ltd